tiprankstipranks
AbCellera Biologics (ABCL)
NASDAQ:ABCL

Compare AbCellera Biologics (ABCL) vs. Competitors

2,298 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
AbCellera Biologics
$3.43
$1.04B
-6.98
77.72%
4 Buy
0 Hold
0 Sell
Strong Buy
Syndax Pharmaceuticals
$24.56
$2.17B
-6.38
132.58%
10 Buy
0 Hold
0 Sell
Strong Buy
Arcus Biosciences
$22.65
$2.84B
-7.25
221.73%
8 Buy
2 Hold
0 Sell
Strong Buy
Dianthus Therapeutics
$87.48
$4.63B
-9.59
488.69%
16 Buy
0 Hold
0 Sell
Strong Buy
Edgewise Therapeutics
$33.04
$3.54B
-12.72
187.55%
7 Buy
0 Hold
0 Sell
Strong Buy
Structure Therapeutics, Inc. Sponsored ADR
$53.11
$3.76B
31.19
275.34%
13 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ABCL
AbCellera Biologics
3.43
1.26
58.06%
SNDX
Syndax Pharmaceuticals
24.56
13.04
113.19%
RCUS
Arcus Biosciences
22.65
14.71
185.26%
DNTH
Dianthus Therapeutics
87.48
71.15
435.70%
EWTX
Edgewise Therapeutics
33.04
20.54
164.32%
GPCR
Structure Therapeutics, Inc. Sponsored ADR
53.11
37.84
247.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts